Living Cell Technologies Limited (LCT)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!

General Information
Company Name: Living Cell Technologies Limited
Stock Code: LCT
GICS Sub-Industry: Biotechnology
Market Cap ($M): 25
Equiv. Shares (M): 406

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.061 $ 0.000 $ 0.000 $ 0.000 $ 0.061 0 0%

Company Overview

Business Description:
Living Cell Technologies (LCT) develops cell therapies to treat diseases with high unmet clinical needs. The Australasian biotechnology company is a global pioneer in the field of cell encapsulation and implantation for human therapeutics. To date, the company has taken two therapeutic candidates into clinical development: DIABECELL® for the treatment of type 1 diabetes and NTCELL®, which is in Phase I clinical trials in New Zealand for the treatment of Parkinson’s disease.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -6.8 -1.9 -- 0.0 0.0 0.0 --
2013  A -3.0 -0.8 -- 0.0 0.0 0.0 --
2012  A 5.7 1.7 -- 3.7 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Bionomics (BNO) $238 M -- 6.3117 0.3108 74.0260 10.1243 7.7236 0.00 0.00 0.00
CSL (CSL) $35,407 M 0.0899 0.1809 0.1147 26.1210 22.1188 19.8431 1.61 1.92 2.10
Living Cell (LCT) $25 M -- -- -- -- -- -- 0.00 -- --
Mesoblast (MSB) $1,226 M -- -- -- -- -- -- 0.00 0.00 0.00
Sirtex Medical (SRX) $1,346 M 0.2906 0.5104 0.3724 57.6513 38.1693 27.8122 0.59 0.76 1.26

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
LCT -- -- 2.58 -- 2.95
Market 1.10 13.9 1.02 1.03 3.00
Sector 0.71 21.0 2.78 1.68 8.44

Name Position Start Date
Professor Robert Bartlett Elliott Medical Director 15 January 2004
Mr Robert Moyse Willcocks Non-Executive Director 29 March 2011
Mr Laurrie Hunter Non-Executive Director 25 August 2006
Dr Bernard Tuch Non-Executive Director 19 July 2011
Mr Roy James Austin Non-Executive Director,Non-Executive Chairman 25 February 2011

Name Position
Kenneth (Ken) P Taylor Chief Executive Officer
Nicholas (Nick) John Victor Geddes Company Secretary
John Cowan Head of Finance & Administration

Substantial Shareholders
Holding Name
24,150,408 (6.76%) Palmert Members Limited
24,150,408 (6.76%) Coalco International Limited
25,000,000 (7.00%) Otsuka Pharmaceutical Factory, Inc
25,610,891 (7.17%) Persistency Private Equity Limited (formerly Prospector Limited)
12,329,061 (3.45%) K One W One Limited

Calendar of Events
Date Event
16 October 2015 Report (Annual)
14 August 2015 Report (Prelim)
24 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Shares via SMSFs

An educational booklet that outlines how to get the most from your share investments for retirement thorugh your self managed super fund.

More details...


Aussie share market bulls now have company

Ric Spooner (Chief Market Analyst, CMC Markets) 20/10/2014 | Today, Australian investors will not have to go it alone buying stocks as they did for much of last week. Bargain hunters this morning will be supported by the morale boosting encouragement of a 3% turnaround in the German Dax and a 264 point rally in the Dow Jones.

The Importance of Ignoring the Noise of the Market

Carl Richards, director of investor education at the BAM Alliance 17/10/2014 | “As odd as it may sound, the sooner you start treating your investments like you treat life, the happier you’ll be with the outcome.”

You only dance twice

William H. Gross, Janus Capital Group 16/10/2014 | “Financial markets are artificially priced. In the bond market, there is nothing normal about a three year German Bund yielding “minus” 10 basis points.”

The Big Picture - Australia 200 Index

CMC Markets 8/10/2014 | Share market indices around the globe are breaking down. While analysts cast around for reasons, it’s clear that a time factor is in play. Simply put, many investors “feel” a correction is overdue. How low could it go?

Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.

Elders alleges $24m fraud in live cattle division

The Age 19/12/2013 | Troubled rural services group Elders is threatening to call in the police over an alleged $24 million fraud by a "handful of individuals" in its live cattle exports division.


Sponsored Links